Method for producing matrices of addressed ligands on a carrier
a technology of ligands and matrices, which is applied in the direction of diaphragms, sequential/parallax process reactions, libraries, etc., can solve the problems of requiring a large number of different masks to carry out all coupling operations, and reducing the size of the si
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
1—Production of Carriers Carrying Oligonucleotides
[0084] The conductive carriers used are glass plates coated with a layer of chromium (for adherence) and a continuous layer of gold of 0.5 μm. This layer is connected to the “working electrode” outlet of an EGG 283 potentiostat.
[0085] Two different oligonucleotides carrying a pyrrole group at 5′ are copolymerised on these carriers. Their sequences are as follows:
pyrM5: 5′ pyr (T)10 GGAGCTGCTGGCGT 3′pyrCP: 5′ pyr (T)10 GCCTTGACGATACAGC 3′
[0086] They were synthesized using the method described by Livache et al in [5].
[0087] To fix these oligonucleotides to the carrier, a reaction medium is used containing 0.1M LiClO4, 20 mM pyrrole and 1 μM oligonucleotide carrying a pyrrole group at 5′.
[0088] This solution is added to a reservoir in polypropylene of cone shape which contains a platinum counter-electrode (CE) connected to the potentiostat. This reservoir is easily filled using a micropipette whose volume may vary from 50 to 1000...
example 2
[0102] The same operating method is followed as in example 1 to prepare matrices of pyrM5 and pyrCP oligonucleotides but using as conductive carrier a carrier in plastic material coated with indium and tin oxide (ITO).
[0103] The results obtained with these matrices for the detection of biotinylated complementary oligonucleotides are the following: [0104] oligonucleotide on pyrM5 carrier hybridised with biocompM5: 95 [0105] oligonucleotide on pyrM5 carrier hybridised with biocompCP: 5 [0106] oligonucleotide on pyrCP carrier hybridised with biocompM5: 7 [0107] oligonucleotide on pyrCP carrier hybridised with biocompCP: 105
example 3
[0108] In this example, the same operating method as in example 1 is followed to prepare a matrix of pyrM5 oligonucleotides on a carrier in gold supported by glass but as counter-electrode a platinum wire is used charged with reaction medium instead of the reservoir fitted on the inside with a platinum electrode.
[0109] As shown in FIG. 4A, the platinum wire 15 is charged with reaction medium by immersion in a reservoir 17 containing this medium. The wire carrying the drop 19 is then brought to the carrier until contact is made with the drop. The electrochemical impulse is then made. The wire is lifted away and rinsed in water. Other deposits are made in the same manner. In this way deposits of approximately 1 mm in diameter are obtained and intense fluorescence is visible when the matrix is used to conduct hybridisation of the complementary oligonucleotide. The results obtained are the following: [0110] oligonucleotide on pyrM5 carrier hybridised with biocompM5: 400 [0111] oligonuc...
PUM
| Property | Measurement | Unit |
|---|---|---|
| size | aaaaa | aaaaa |
| diameter | aaaaa | aaaaa |
| diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


